⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16349458 | 1.00 | — | — | |
| SCHEMBL5956982 | 1.00 | — | — | |
| SCHEMBL15671215 | 0.72 | — | — | |
| SCHEMBL5590128 | 0.69 | — | — | |
| SCHEMBL18756528 | 0.69 | — | — | |
| SCHEMBL5590122 | 0.69 | — | — | |
| SCHEMBL8424496 | 0.67 | — | — | |
| SCHEMBL20785048 | 0.67 | — | — | |
| SCHEMBL11797239 | 0.67 | — | — | |
| SCHEMBL13844625 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108778230-A | Alginate impression material for dentistry | 株式会社GC | 2018-11-09 | — | — | CN | disclosed |
| US-20060061265-A1 | Aromatic amine derivative and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2006-03-23 | — | — | US | disclosed |
| EP-1559706-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2005-08-03 | — | — | EP | disclosed |
| US-5698363-A | IMAGEWISE PROVIDING IN SECOND LAYER COMPONENT NOT IN FIRST LAYER, SELECTED FROM COBALT COMPLEX HAVING AMMONIA OR PRIMARY AMINE LIGAND, COMPOUND HAVING ABSORPTION WAVELENGTH CHANGED BY LIGAND, COMPOUND CAUSING LIGAND TO BE RELEASED | KONICA CORPORATION (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0753415-A2 | Image forming method | KONICA CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |